Dolby Laboratories, Inc.
Financial highlights
| Metric | FY September 26, 2025 | FY September 27, 2024 | FY September 29, 2023 | FY September 30, 2022 | FY September 24, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross profit | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M |
| Operating expenses | $924.0M | $874.9M | $931.4M | $905.8M | $806.8M |
| Cost of revenue | $160.1M | $140.5M | $152.6M | $141.4M | $130.0M |
| Cash from operations | $472.2M | $327.3M | $367.1M | $318.6M | $447.8M |
| Capital expenditure | $36.3M | $30.0M | $30.3M | $47.9M | $54.5M |
| Free cash flow | $435.9M | $297.2M | $336.7M | $270.6M | $393.3M |
| Share repurchases | $125.0M | $160.0M | $149.3M | $530.5M | $245.9M |
| Total assets | $3.2B | $3.1B | $3.0B | $2.7B | $3.1B |
| Total liabilities | $595.8M | $623.0M | $607.6M | $438.5M | $501.5M |
Shares outstanding 94.6M · Free float 25.4%
Annual filing data through FY ended September 26, 2025; float as of July 12, 2026.